Joseph Burke
Family Medicine · Keller, TXNPI 1497799308
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 77 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 24 manufacturers, the largest accounting for just 15.4% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $833 and has fallen 96.2% since, to $31 in 2025.
Across 77 payments — averaging $20.01 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$237
- Stryker$192
- AstraZeneca$148
- AbbVie$120
- Medtronic$113
- Amgen$78
- plus $652 from 18 others
What the payments were for
- Food & beverage$1,541100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 11 | $237 |
| Stryker | 2 | $192 |
| AstraZeneca | 9 | $148 |
| AbbVie(2 entities) | 7 | $120 |
| Medtronic(2 entities) | 2 | $113 |
| Amgen | 5 | $78 |
| Amarin Pharma, Inc. | 4 | $67 |
| E.r. Squibb & Sons, L.L.C. | 1 | $59 |
| Daiichi Sankyo Inc. | 3 | $51 |
| GSK | 3 | $51 |
| Boehringer Ingelheim | 3 | $48 |
| Abbott | 3 | $44 |
| Lilly USA, LLC | 3 | $41 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 2 | $36 |
| Teva Pharmaceuticals USA, Inc. | 3 | $33 |
| Novartis | 2 | $31 |
| Genentech USA, Inc. | 2 | $30 |
| Sanofi Pasteur Inc. | 2 | $29 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $27 |
| Merck | 2 | $25 |
| Bioventus LLC | 1 | $25 |
| Johnson & Johnson | 2 | $24 |
| Astellas Pharma US Inc | 1 | $18 |
| Althera Pharmaceuticals LLC | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$1,541 in reported general payments places this provider in the 70th percentile of 8,760 family medicine providers in Texas.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Rosuvastatin Calcium | 13 | $162 |
| Atorvastatin Calcium | 14 | $112 |
Paid to pharmacies, not to this prescriber.
Other family medicine in Keller
- Carlos CamposNew Braunfels$1.5M
- Aaron KingSan Antonio$1.1M
- Bradley WassonArlington$734K
- Cynthia BrinsonAustin$402K
- Michael MendezLubbock$368K
- Sang Tae KimAmarillo$368K
- Sumit PerakathuHarlingen$342K
- Joel SolisMcAllen$324K
- Robert CampbellFort Worth$318K
- Jose LedezmaEdinburg$300K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.